Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

Autor: G. Pellejero, Jose Gutierrez, R. Malý, M. Basaglia, L. Chasco, P. Suchon, R. Le Mao, Laurent Bertoletti, F. Martins, J. Caprini, A. Braester, F. Galeano-Valle, Hanh My Bui, J. Alonso, Y. Sato, G. Vidal, Y. Nishimoto, C. Tolosa, E. Nofuentes-Pérez, A.M. Díaz-Brasero, N. Ait Abdallah, M.D. Adarraga, R. Sánchez-Martínez, L. Font, Raquel López-Reyes, Inna Tzoran, Karine Lacut, J. del Toro, Andris Skride, Ana Jaureguizar, Joseph A. Caprini, C. Amado, R. García de la Garza, A.M. Camon, S. Merla, Luciano López-Jiménez, G. Salgueiro, Sebastian Schellong, Alfonso Muriel, F. Bilora, S. Lainez-Justo, B. Suárez-Rodríguez, Carme Font, F. Beddar Chaib, I. Francisco, C. Jiménez-Alfaro, P. Azcarate-Agüero, Maurizio Ciammaichella, J.A. Porras, N. Vo Hong, F. Martín-Martos, Dominique Farge-Bancel, D. Farge-Bancel, José Luis Lobo, M. Giménez-Suau, E. Grau, F. García-Bragado, Ángeles Blanco-Molina, Carmen Fernández-Capitán, María del Carmen Díaz-Pedroche, C. Grange, Adriana Visonà, L. Guirado, P. Villares, P. López-Miguel, José María Pedrajas, S. Accassat, Beatriz Valero, B. Crichi, Juan J. López-Núñez, Luis Jara-Palomares, G. Sarlon-Bartoli, J. Lima, C. Bortoluzzi, Alicia Lorenzo, C. de Ancos, M.A. Fidalgo, Philippe Debourdeau, Pablo Javier Marchena, C. Rodríguez-Matute, A.I. Farfán-Sedano, José Luis Fernández-Reyes, J.C. Escribano, Juan I. Arcelus, M. Barrón, I. Quere, Remedios Otero, A. De Angelis, P. Morange, Peter Verhamme, G. Kenet, P. Prandoni, Pedro Ruiz-Artacho, C. Siniscalchi, A. Zaicenko, M. Olid-Velilla, C. García-Díaz, B. Barrón-Andrés, T. Sancho, Fernando Uresandi, Javier Trujillo-Santos, A. Muñoz-Blanco, A. Villalobos, A. Dubois-Silva, J. Moisés, J. Osorio, M.I. Mercado, J.M. Suriñach, M.A. Aibar, M.D. Joya, Cihan Ay, J.A. Díaz-Peromingo, H. Bounameaux, Diego Martínez-Urbistondo, Thomas Vanassche, L. Bertoletti, Marijan Bosevski, Farès Moustafa, M. Martín del Pozo, J.F. Sánchez-Muñoz-Torrero, H.M. Bui, Ingrid Pabinger, M.C. Olivares, M. García de Herreros, M.J. Núñez-Fernández, B. Zalunardo, J.F. Varona, Stephan Nopp, Behnood Bikdeli, B. Brandolin, B. Bikdeli, Olga Madridano, Manuel Monreal, M.J. Jaras, Alessandra Bura-Rivière, Abílio Reis, J. Portillo, O. Espitia, J. Catella, Aitor Ballaz, F. Esposito, R. Barba, R. Valle, H. Helfer, I. Tzoran, J.B. López-Sáez, P. Ruiz-Artacho, M.A. García, J. Aibar, C. Gómez-Cuervo, C. Gabara, A. Latorre, J. Ruiz-Ruiz, Benjamin Brenner, S. Fonseca, S. Schellong, Raffaele Pesavento, Barry M. Brenner, Silvia Soler, Paolo Prandoni, Victor F. Tapson, Ana Maestre, Pierpaolo Di Micco, M. Muñoz, J. Criado, D. Jiménez, Antonella Tufano, G. Krstevski, B. Valero, Henri Bounameaux, M.I. Torres, G. Poenou, Isabelle Mahé, Aída Gil-Díaz, A. Asuero, S. Otalora, V. Rosa, L. Vela, E. Imbalzano, C. Vandenbriele, C. Barbagelata, Jana Hirmerova, J. Meireles, David Jiménez, Lucia Mazzolai, L. Hernández-Blasco, M. Bosevski, Gili Kenet, C. Mella, M. Monreal, J.R. Vela, P. Di Micco, Carlos Zamora, K. Flores, P. Demelo-Rodríguez, Radovan Malý, J. Birzulis, J.A. Nieto, J. Castro, M.V. Di Campli, Francis Couturaud, Raquel Barba

Publikováno v: Chest. 161:524-534

Background: The association between heart rate (HR) and pulmonary embolism (PE) outcomes has not been well studied. Furthermore, optimal cutoffs to identify low-risk and intermediate- to high-risk patients are not well known. Research Question: Does

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d87f95f0e34e2d8fc85a582502f637
https://doi.org/10.1016/j.chest.2021.08.059

Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies

Autor: Léa Vazquez, Philippe Debourdeau, Anne Lamblin, Théodore Debourdeau, Pierre Yves Marcy

Publikováno v: Journal of Thrombosis and Haemostasis. 19:2659-2673

Symptomatic catheter related thrombosis (CRT) occurs in 4%-8% of cancer patients. The mean incidence of CRT, detected either by echography or Doppler ranges between 12 and 14% with a high negative predictive value of about 95%, allowing the subsequen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbde5b9423160c0ed31f34b144a09ab1
https://doi.org/10.1111/jth.15487

Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ?

Autor: J. Grenier, Philippe Debourdeau, Léa Vazquez, Antoine Arnaud

Publikováno v: Bulletin du Cancer. 108:544-552

Resume Introduction L’adjonction du palbociclib a l’hormonotherapie ameliore la survie sans progression chez les patients atteints d’un cancer du sein metastatique positif aux recepteurs hormonaux. Cette nouvelle therapie ciblee expose cependan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f9442d9a75c1cc2bf906f361c599b96
https://doi.org/10.1016/j.bulcan.2021.01.007

Three-month outcomes in cancer patients with superficial- or deep vein thrombosis in the lower limbs. Results from the RIETE Registry

Autor: Philippe DEBOURDEAU, Laurent BERTOLETTI, Carme FONT, Juan José LÓPEZ-NÚÑEZ, Covadonga GÓMEZ-CUERVO, Isabelle MAHÉ, Remedios OTERO, María Dolores ADARRAGA, Patricia LÓPEZ-MIGUEL, Manuel MONREAL

Background: The clinical characteristics and outcomes of cancer patients presenting with lower-limb isolated superficial vein thrombosis (SVT) have not been consistently evaluated.Methods: We used data in the RIETE registry to compare the clinical ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e21a07cc59428c817fbdaaa2382808a8
https://doi.org/10.21203/rs.3.rs-1500920/v1

Héparines de bas poids moléculaires dans la maladie thromboembolique veineuse liée au cancer : quelle place en 2019 ?

Autor: Thierry Takam-Sohwe, Philippe Debourdeau, Jean-Pierre Laroche, Cresent Cossou-Gbeto

Publikováno v: Bulletin du Cancer. 107:224-233

According to international clinical practice guidelines, low-molecular-weight heparins are advocate for the treatment and the prevention of cancer associated thrombosis. Direct oral anticoagulants recently introduced represent an alternative to vitam

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0bd3e7fb763b135cc8cf1df8f6aa74e3
https://doi.org/10.1016/j.bulcan.2019.11.007